Browsing: lands

With programs targeting Alzheimer’s and Parkinson’s, company targets several major drivers of neurodegenerative disease. US biotech SciNeuro Pharmaceuticals has secured…

Approach aims to identify multiple disease-driven molecular changes, long before cognitive decline becomes apparent. Brain health diagnostics company Circular Genomics…

MindImmune targets clinical trials of drug that blocks the harmful recruitment of peripheral immune cells into the brain. US biotech…

Company’s Parkinson’s therapy is designed to restore dopamine function by rebuilding neural networks using a patient’s own stem cells. US…

Depending on where the flies had been before, they can leave behind pathogenic microbes on the food they land on…

Nature, Published online: 31 October 2025; doi:10.1038/d41586-025-03512-8The moisture emitted by forests travels across national borders to provide precipitation to far-away…

By enhancing mitochondrial quality control, company aims to improve neuronal health and modify the course of neurodegeneration. British biotech Mission…

Algen Biotechnologies is combining CRISPR and AI to decode the root cause of disease and accelerate new drug development. In…

ACI now acts as “commercial gateway” for Dolcas by distributing the marine collagen tripeptide in the UK, supplying samples, clinical…

Company targets confirmatory trials of immunomodulator shown to slow cognitive decline when used as a control arm. Longevity biotech Advantage…